- Home
- PAHC vs AAMI Comparison
PAHC vs AAMI Comparison
Compare PAHC & AAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAHC
- AAMI
- Stock Information
- Founded
- PAHC 1946
- AAMI 1980
- Country
- PAHC United States
- AAMI United States
- Employees
- PAHC N/A
- AAMI N/A
- Industry
- PAHC Biotechnology: Pharmaceutical Preparations
- AAMI Investment Managers
- Sector
- PAHC Health Care
- AAMI Finance
- Exchange
- PAHC Nasdaq
- AAMI Nasdaq
- Market Cap
- PAHC 812.1M
- AAMI 964.3M
- IPO Year
- PAHC 2014
- AAMI N/A
- Fundamental
- Price
- PAHC $20.82
- AAMI $24.98
- Analyst Decision
- PAHC Sell
- AAMI
- Analyst Count
- PAHC 4
- AAMI 0
- Target Price
- PAHC $20.50
- AAMI N/A
- AVG Volume (30 Days)
- PAHC 183.3K
- AAMI 217.1K
- Earning Date
- PAHC 02-05-2025
- AAMI 02-06-2025
- Dividend Yield
- PAHC 2.88%
- AAMI 0.16%
- EPS Growth
- PAHC N/A
- AAMI N/A
- EPS
- PAHC 0.43
- AAMI 1.65
- Revenue
- PAHC $1,046,762,000.00
- AAMI $469,000,000.00
- Revenue This Year
- PAHC $27.25
- AAMI $16.77
- Revenue Next Year
- PAHC $14.13
- AAMI $8.38
- P/E Ratio
- PAHC $48.45
- AAMI $15.10
- Revenue Growth
- PAHC 7.17
- AAMI 12.17
- 52 Week Low
- PAHC $10.04
- AAMI $19.85
- 52 Week High
- PAHC $25.98
- AAMI $31.52
- Technical
- Relative Strength Index (RSI)
- PAHC 42.91
- AAMI N/A
- Support Level
- PAHC $19.74
- AAMI N/A
- Resistance Level
- PAHC $21.82
- AAMI N/A
- Average True Range (ATR)
- PAHC 0.75
- AAMI 0.00
- MACD
- PAHC 0.08
- AAMI 0.00
- Stochastic Oscillator
- PAHC 51.43
- AAMI 0.00
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.